Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease

Clinical trial NCT05258682 · UNKNOWN

Trial details

NCT number: NCT05258682
Sponsor: Mucpharm Pty Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Pneumonia COVID-19 Ventilator Associated Pneumonia COVID-19 Acute Respiratory Distress Syndrome

Start date: 2022-05-01
Primary completion: 2022-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.